Description

TB-500 (Thymosin Beta-4 Acetate) and BPC-157 (Body Protection Compound) are two synthetic peptides with complementary mechanisms that support tissue regeneration and inflammation control. When combined, they are investigated for their synergistic potential in accelerating recovery in models of muscle, tendon, ligament, nerve, and gastrointestinal injury.

TB-500 promotes cell migration, angiogenesis, and extracellular matrix remodeling through its regulation of actin dynamics and upregulation of growth factors like VEGF. It is especially effective in enhancing blood flow and reducing fibrosis in damaged tissues.

BPC-157, a stable gastric peptide fragment, interacts with the nitric oxide system and supports collagen synthesis, vascular repair, and anti-inflammatory signaling. It has shown strong protective effects in models of gastrointestinal injury, soft tissue trauma, and systemic inflammation.

Research involving this dual-peptide set focuses on multi-system tissue recovery, wound healing, and accelerated regeneration, making it of interest in orthopedic, neurological, and gastrointestinal studies. The 5 mg dosage of each compound provides a balanced profile for evaluating both localized and systemic regenerative outcomes.